Status:
COMPLETED
Paravertebral Block for Percutaneous Radiofrequency Ablation of Liver Lesions
Lead Sponsor:
Campus Bio-Medico University
Conditions:
Liver Tumor
Eligibility:
All Genders
18+ years
Brief Summary
Percutaneous radiofrequency ablation of liver lesions causes patients acute pain during and after the procedure. During the procedure patients need deep sedation and cannot be collaborative. Furthermo...
Detailed Description
The purpose of this study is to evaluate if single injection TPVB, ultrasound guided, ENS assisted, is advantageous compared to deep sedation (DS)in patients undergoing percutaneous radiofrequency abl...
Eligibility Criteria
Inclusion
- written consent ASA I-III
Exclusion
- allergy to local anesthetic infection in the site of planned injection
Key Trial Info
Start Date :
December 1 2012
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
September 1 2022
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT01812577
Start Date
December 1 2012
End Date
September 1 2022
Last Update
August 23 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Campus Bio-Medico
Rome, Italy/RM, Italy, 00121